SPI1 |
BMDM (bone marrow-derived macrophages) |
LXRD KO |
Permissive
Robust
|
Mus musculus |
GSE21512
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS (10 ng/ml) for 24hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IL4 (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
TNFa (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
TGFb1 (1 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IL1b (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
MALP2 (1 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
CpG (100 nM) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat6ko ctrl |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat6ko ctrl, IL4 (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat6ko |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat6 ko, IL4 (10 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat1ko ctrl |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat1ko ctrl, IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat1ko |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
stat1ko, IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 30min |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 1hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 2hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
Tot2 (myeloid progenitor cell line) |
MSCV-IRF8 transduced |
Permissive
Robust
|
Mus musculus |
GSE38824
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
100 ng/ml Kdo2-LipidA 1 hr |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
100 ng/ml Kdo2-LipidA 1 hr |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE46494
...
|
MA0080.5
|
SPI1 |
B-cells |
stimulated for 1 day |
Permissive
Robust
|
Mus musculus |
GSE46607
...
|
MA0080.5
|
SPI1 |
B-cells |
stimulated for 3 days |
Permissive
Robust
|
Mus musculus |
GSE46607
...
|
MA0080.5
|
SPI1 |
3T3-L1 (embryonic fibroblasts) |
adeno-PU1 |
Permissive
Robust
|
Mus musculus |
GSE48343
...
|
MA0080.5
|
SPI1 |
macrophages |
none |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
Kdo2 Lipid A (KLA) 1h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
Kdo2 Lipid A (KLA) 6h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
Kdo2 Lipid A (KLA) 12h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
Kdo2 Lipid A (KLA) 24h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
DMSO 7h, Kdo2 Lipid A (KLA) 6h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
Flavopiridol 7h, Kdo2 Lipid A (KLA) 6h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
DMSO 2h, Kdo2 Lipid A (KLA) 1h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
macrophages |
IBET 2h, Kdo2 Lipid A (KLA) 1h |
Permissive
Robust
|
Mus musculus |
GSE48759
...
|
MA0080.5
|
SPI1 |
BV-2 (brain microglial cells) |
wt human Htt overexpression |
Permissive
Robust
|
Mus musculus |
GSE54443
...
|
MA0080.5
|
SPI1 |
BV-2 (brain microglial cells) |
mutant human Htt overexpression |
Permissive
Robust
|
Mus musculus |
GSE54443
...
|
MA0080.5
|
SPI1 |
C10 (pre-B-cells) |
0.1% ethanol as control sample |
Permissive
Robust
|
Mus musculus |
GSE53362
...
|
MA0080.5
|
SPI1 |
C10 (pre-B-cells) |
100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1 |
Permissive
Robust
|
Mus musculus |
GSE53362
...
|
MA0080.5
|
SPI1 |
C10 (pre-B-cells) |
100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1 |
Permissive
Robust
|
Mus musculus |
GSE53362
...
|
MA0080.5
|
SPI1 |
C10 (pre-B-cells) |
100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1 |
Permissive
Robust
|
Mus musculus |
GSE53362
...
|
MA0080.5
|
SPI1 |
C10 (pre-B-cells) |
100 nM of beta-estradiol + 10 nM of IL-3 and CSF-1 |
Permissive
Robust
|
Mus musculus |
GSE53362
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 2 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 4 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 2 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 4 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
B-cells |
LPS and IL-4 |
Permissive
|
Mus musculus |
GSE61424
...
|
MA0080.5
|
SPI1 |
B-cells |
LPS and IL-4 |
Permissive
Robust
|
Mus musculus |
GSE61424
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
4ng/ml Mcsf 7d, 2um DMSO 7d |
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
4ng/ml Mcsf 7d, 2um ATRA 7d |
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
4ng/ml Mcsf 7d, 1ng/ml TGFB1 7d |
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
4ng/ml Mcsf 7d, 1ng/ml VehTGFB1 7d |
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
X18.1.1 (acute myeloid leukemia) |
PuER |
Permissive
Robust
|
Mus musculus |
GSE63317
...
|
MA0080.5
|
SPI1 |
embryonic stem cell-derived hematopoietic progenitors |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0080.5
|
SPI1 |
embryonic stem cell-derived macrophages |
none |
Permissive
Robust
|
Mus musculus |
GSE69099
...
|
MA0080.5
|
SPI1 |
B-cells |
Cebpa18h |
Permissive
Robust
|
Mus musculus |
GSE71215
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
vehicle 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
tissuehomogenate 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0080.5
|
SPI1 |
macrophages |
Maf-DKO |
Permissive
Robust
|
Mus musculus |
GSE75722
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
no treatment |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (400U/ml) 0.5h |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
IFNg (400U/ml) 3h |
Permissive
Robust
|
Mus musculus |
GSE77884
...
|
MA0080.5
|
SPI1 |
monocyte-derived macrophages |
untreated |
Permissive
Robust
|
Homo sapiens |
GSE100889
...
|
MA0080.5
|
SPI1 |
monocyte-derived macrophages |
IL-4 |
Permissive
Robust
|
Homo sapiens |
GSE100889
...
|
MA0080.5
|
SPI1 |
BN cells (granulocyte-macrophage progenitor) |
1000 ng/ml doxycycline |
Permissive
Robust
|
Mus musculus |
GSE79191
...
|
MA0080.5
|
SPI1 |
pro-B cells |
induced |
Permissive
Robust
|
Mus musculus |
GSE87314
...
|
MA0080.5
|
SPI1 |
pro-B cells |
induced |
Permissive
Robust
|
Mus musculus |
GSE87314
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
No treatment |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
alpha amanitin 10μg/ml for 5 hours (SIGMA) |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0080.5
|
SPI1 |
bone marrow |
Untreated |
Permissive
Robust
|
Mus musculus |
GSE87623
...
|
MA0080.5
|
SPI1 |
monocyte-derived macrophages |
IFN-gamma |
Permissive
Robust
|
Homo sapiens |
GSE98367
...
|
MA0080.5
|
SPI1 |
monocyte-derived macrophages |
none |
Permissive
Robust
|
Homo sapiens |
GSE98367
...
|
MA0080.5
|
SPI1 |
monocyte-derived macrophages |
LPS |
Permissive
Robust
|
Homo sapiens |
GSE104638
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
control |
Permissive
Robust
|
Mus musculus |
GSE106701
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
Mouse bone marrow-derived macrophages were treated with IL-4 (20 ng/ml; 1 hour). |
Permissive
Robust
|
Mus musculus |
GSE106701
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
1h IL4 |
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0080.5
|
SPI1 |
MDM(monocyte derived macrophages) |
Treatment: mock infected 6hr |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
MDM(monocyte derived macrophages) |
Treatment: H5N1 IAV infected 6hr |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
MDM(monocyte derived macrophages) |
Treatment: H5N1-dNS1 IAV infected 6hr |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
MDM(monocyte derived macrophages) |
Treatment: IFNb treated 6hr |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: untreated, eGFP(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: Pam3csk4 treated 4hr, eGFP(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: untreated, IAV NS1(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: Pam3csk4 treated 4hr, IAV NS1(EP mRNA) |
Permissive
Robust
|
Homo sapiens |
GSE103477
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: DMSO for 24 hr in RPMI with 10% fetal bovine serum |
Permissive
Robust
|
Homo sapiens |
GSE112074
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: 250nM OG86 for 24 hr in RPMI with 10% fetal bovine serum |
Permissive
Robust
|
Homo sapiens |
GSE112074
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: 100nM VDR ligand 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) for 24 hrs Cell type: human monocytic cell line |
Permissive
Robust
|
Homo sapiens |
GSE89178
...
|
MA0080.5
|
SPI1 |
THP-1 (acute monocytic leukemia) |
Treatment: EtOH (vehicle) for 24hrs Cell type: human monocytic cell line |
Permissive
Robust
|
Homo sapiens |
GSE89178
...
|
MA0080.5
|
SPI1 |
Lin- bone marrow hematopoietic progenitor cells |
Strain: C57BL/6 Genotype: UTX wildtype |
Permissive
Robust
|
Mus musculus |
GSE101307
...
|
MA0080.5
|
SPI1 |
Lin- bone marrow hematopoietic progenitor cells |
Strain: C57BL/6 Genotype: UTX knockout |
Permissive
Robust
|
Mus musculus |
GSE101307
...
|
MA0080.5
|
SPI1 |
bone marrow myeloid cells |
CSF1 only |
Permissive
Robust
|
Mus musculus |
GSE107294
...
|
MA0080.5
|
SPI1 |
bone marrow myeloid cells |
CSF1 and RANKL for 36h |
Permissive
Robust
|
Mus musculus |
GSE107294
...
|
MA0080.5
|
SPI1 |
bone marrow myeloid cells |
CSF1 and RANKL for 72h |
Permissive
Robust
|
Mus musculus |
GSE107294
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; C57BL/6J x SPRET/EiJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
C57BL/6J x SPRET/EiJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; SPRET/EiJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
SPRET/EiJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; PWK/PhJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
PWK/PhJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; NOD/ShiLtJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
NOD/ShiLtJ strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; C57BL/6J x PWK/PhJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
C57BL/6J x PWK/PhJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
C57BL/6J strain |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
KLA 1h; BALB/cJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
BALB/cJ |
Permissive
Robust
|
Mus musculus |
GSE109965
...
|
MA0080.5
|
SPI1 |
dendritic cells |
Strain: C56BL/6 Cell type: Conventional dendritic cells |
Permissive
Robust
|
Mus musculus |
GSE121544
...
|
MA0080.5
|
SPI1 |
dendritic cells |
Strain: C56BL/6 Cell type: Plasmacytoid dentritic cells |
Permissive
Robust
|
Mus musculus |
GSE121544
...
|
MA0080.5
|
SPI1 |
CFU-M |
Genotype: wildtype, cell markers Lin- Sca1- cKit+ CD150- CD41- FcgRII/III(hi) CD115+ Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
LSK |
Genotype: wildtype, cell markers Lin-, Sca-1+, ckit Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
preGM |
Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105- Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
preGM |
Genotype: CEBPA knockout, cell markers Lin-, Sca-1-, ckit+, CD150-, CD105- Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
GMP |
Genotype: wildtype, cell markers Lin-, Sca-1-, ckit+, CD150-, FcgRII/III+ Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
CFU-G |
Genotype: wildtype, cell markers Lin- Sca1-cKit+ CD150- CD41- FcgRII/III(hi) CD115- Tissue: bone marrow |
Permissive
Robust
|
Mus musculus |
GSE89767
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: transduced with Lzr-EVGFP, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: Transduced with Lzr-PU1WTHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: Transduced with Lzr-PU1ENGHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
Lin- FLP derived CD25+ |
Treatment: Transduced with Lzr-PU1ETSHA, cultured on OP9DL1 Strain: C57BL6/J Age: E13.5 |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: transduced with Lzr-PU1WTHA Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Transduced with Lzr-PU1WTHA |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Unperturbed (DSG+FA) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-ert2, treated 24 hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-PU.1ert2, treated 2hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-ert2, treated 0hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-PU.1ert2, treated 8hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with Lzr-PU.1ert2, treated 24hrs 0.1 uM 4-OHT (4-hydroxytamoxifen) Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0080.5
|
SPI1 |
CD4+ T-cells |
Source: Th9 Naive T cells from spleen and nodes Genotype: wildtype Strain: C57/Bl6j Age:7 weeks |
Permissive
|
Mus musculus |
GSE99165
...
|
MA0080.5
|
SPI1 |
GM12878 (female B-cells lymphoblastoid cell line) |
Characteristic: robotic ChIP-seq; |
Permissive
Robust
|
Homo sapiens |
GSE53366
...
|
MA0080.5
|
SPI1 |
neutrophils derived from immortalized progenitors |
Treatment: unstimulated; Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1; |
Permissive
Robust
|
Mus musculus |
GSE110863
...
|
MA0080.5
|
SPI1 |
neutrophils derived from immortalized progenitors |
Treatment: stimulated for 1 hour with Candida albicans (heat-inactivated); Strain: MRP8-Cre-ires/GFP (PU.1 WT); Genotype: HoxER-PU.1; |
Permissive
Robust
|
Mus musculus |
GSE110863
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0080.5
|
SPI1 |
spleen + lymph nodes |
Strain: C57BL/6; Genotype: wildtype; Source: FACS-purified FO B cell; |
Permissive
Robust
|
Mus musculus |
GSE128166
...
|
MA0080.5
|
SPI1 |
MEL(mouse erythroleukemia cells) |
Time: day0; Treatment: none; |
Permissive
Robust
|
Mus musculus |
GSE67955
...
|
MA0080.5
|
SPI1 |
MEL(mouse erythroleukemia cells) |
Time: day5; Treatment: 2% DMSO (VWR) added to the medium; |
Permissive
Robust
|
Mus musculus |
GSE67955
...
|
MA0080.5
|
SPI1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BGQ
|
MA0080.5
|
SPI1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BGW
|
MA0080.5
|
SPI1 |
GM12891 (male B- cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BIJ
|
MA0080.5
|
SPI1 |
HL-60 (acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUW
|
MA0080.5
|
SPI1 |
erythroleukemic cells |
|
Permissive
Robust
|
Mus musculus |
GSE21950
...
|
MA0080.5
|
SPI1 |
embryonic stem cell-derived erythroid progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE21950
...
|
MA0080.5
|
SPI1 |
embryonic stem cell-derived haematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE22178
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE21314
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE21512
...
|
MA0080.5
|
SPI1 |
fetal liver precursors |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0080.5
|
SPI1 |
fetal liver precursors |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0080.5
|
SPI1 |
fetal liver precursors |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0080.5
|
SPI1 |
T-cells |
|
Permissive
|
Mus musculus |
GSE31233
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0080.5
|
SPI1 |
RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE45914
...
|
MA0080.5
|
SPI1 |
RAW 264.7 (Abelson murine leukemia virus-induced tumor-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE45914
...
|
MA0080.5
|
SPI1 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0080.5
|
SPI1 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0080.5
|
SPI1 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0080.5
|
SPI1 |
pro-B cells |
|
Permissive
Robust
|
Mus musculus |
GSE53595
...
|
MA0080.5
|
SPI1 |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE50762
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE50762
...
|
MA0080.5
|
SPI1 |
BV-2 (brain microglial cells) |
|
Permissive
Robust
|
Mus musculus |
GSE54443
...
|
MA0080.5
|
SPI1 |
immature granulocytes |
|
Permissive
Robust
|
Mus musculus |
GSE42110
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0080.5
|
SPI1 |
multipotent hematopoietic progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE57563
...
|
MA0080.5
|
SPI1 |
common dendritic cell progenitors |
|
Permissive
Robust
|
Mus musculus |
GSE57563
...
|
MA0080.5
|
SPI1 |
dendritic cells |
|
Permissive
Robust
|
Mus musculus |
GSE57563
...
|
MA0080.5
|
SPI1 |
plasmacytoid dendritic cells |
|
Permissive
Robust
|
Mus musculus |
GSE57563
...
|
MA0080.5
|
SPI1 |
WEHI-279 (lymphoma) |
|
Permissive
Robust
|
Mus musculus |
GSE58128
...
|
MA0080.5
|
SPI1 |
monocyte-derived dendritic cells |
|
Permissive
Robust
|
Mus musculus |
GSE62702
...
|
MA0080.5
|
SPI1 |
plasmacytoid dendritic cells |
|
Permissive
Robust
|
Mus musculus |
GSE62702
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
small peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
microglia |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
large peritoneal macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
microglia |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
microglia |
|
Permissive
Robust
|
Mus musculus |
GSE62826
...
|
MA0080.5
|
SPI1 |
X18.1.1 (acute myeloid leukemia) |
|
Permissive
Robust
|
Mus musculus |
GSE63317
...
|
MA0080.5
|
SPI1 |
acute myeloid leukemia |
|
Permissive
Robust
|
Mus musculus |
GSE66122
...
|
MA0080.5
|
SPI1 |
B lymphoblastic leukemia |
|
Permissive
Robust
|
Mus musculus |
GSE66233
...
|
MA0080.5
|
SPI1 |
416B (hematopoietic precursor cells) |
|
Permissive
Robust
|
Mus musculus |
GSE69776
...
|
MA0080.5
|
SPI1 |
B-cells |
|
Permissive
Robust
|
Mus musculus |
GSE71215
...
|
MA0080.5
|
SPI1 |
plasmablasts |
|
Permissive
Robust
|
Mus musculus |
GSE71698
...
|
MA0080.5
|
SPI1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE75722
...
|
MA0080.5
|
SPI1 |
alveolar macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE75722
...
|
MA0080.5
|
SPI1 |
BN cells (granulocyte-macrophage progenitor) |
|
Permissive
Robust
|
Mus musculus |
GSE79191
...
|
MA0080.5
|
SPI1 |
Ly6Chi monocytes |
|
Permissive
Robust
|
Mus musculus |
GSE80031
...
|
MA0080.5
|
SPI1 |
Ly6Clo monocytes |
|
Permissive
Robust
|
Mus musculus |
GSE80031
...
|
MA0080.5
|
SPI1 |
Hoxb8-FL |
|
Permissive
Robust
|
Mus musculus |
GSE84328
...
|
MA0080.5
|
SPI1 |
microglia |
|
Permissive
Robust
|
Mus musculus |
GSE89960
...
|
MA0080.5
|
SPI1 |
bone marrow-derived macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE107456
...
|
MA0080.5
|
SPI1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE53366
...
|
MA0080.5
|
SPI1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE53366
...
|
MA0080.5
|
SPI1 |
LCL (lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ERP004110
|
MA0080.5
|
SPI1 |
ME-1 (acute myeloid leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE46044
|
MA0080.5
|
SPI1 |
H929 (plasma cell myeloma) |
|
Permissive
Robust
|
Homo sapiens |
GSE56857
|
MA0080.5
|
SPI1 |
OCI-LY10 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE56857
|
MA0080.5
|
SPI1 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE58864
|
MA0080.5
|
SPI1 |
DOHH2 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE69558
|
MA0080.5
|
SPI1 |
OCI-LY7 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE69558
|
MA0080.5
|
SPI1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE70482
|
MA0080.5
|
SPI1 |
macrophages |
IFNG |
Permissive
|
Homo sapiens |
GSE47188
|
MA0080.5
|
SPI1 |
macrophages |
IL4 |
Permissive
Robust
|
Homo sapiens |
GSE47188
|
MA0080.5
|
SPI1 |
OCI-LY3 (diffuse large B-cell lymphoma) |
SHCTR |
Permissive
Robust
|
Homo sapiens |
GSE56857
|
MA0080.5
|
SPI1 |
OCI-LY3 (diffuse large B-cell lymphoma) |
SHSPIB |
Permissive
Robust
|
Homo sapiens |
GSE56857
|
MA0080.5
|
SPI1 |
Kasumi-1 (acute myeloblastic leukemia) |
SICTR |
Permissive
Robust
|
Homo sapiens |
GSE60130
|
MA0080.5
|
SPI1 |
Kasumi-1 (acute myeloblastic leukemia) |
SIRUNX1ETO |
Permissive
Robust
|
Homo sapiens |
GSE60130
|
MA0080.5
|
SPI1 |
macrophages |
IFNG |
Permissive
Robust
|
Homo sapiens |
GSE66594
|
MA0080.5
|
SPI1 |
macrophages |
IL4 |
Permissive
Robust
|
Homo sapiens |
GSE66594
|
MA0080.5
|
SPI1 |
macrophages |
TPP |
Permissive
Robust
|
Homo sapiens |
GSE66594
|
MA0080.5
|
SPI1 |
CD34+ cells |
ADULT |
Permissive
Robust
|
Homo sapiens |
GSE70660
|
MA0080.5
|
SPI1 |
CD34+ cells |
FETAL |
Permissive
Robust
|
Homo sapiens |
GSE70660
|
MA0080.5
|
SPI1 |
RS4-11 (adult B acute lymphoblastic leukemia) |
DEX |
Permissive
Robust
|
Homo sapiens |
GSE71616
|
MA0080.5
|
SPI1 |
K562 (myelogenous leukemia) |
NABUT |
Permissive
Robust
|
Homo sapiens |
GSE74999
|
MA0080.5
|
SPI1 |
K562 (myelogenous leukemia) |
SAHA |
Permissive
Robust
|
Homo sapiens |
GSE74999
|
MA0080.5
|
SPI1 |
OCI-LY3 (diffuse large B-cell lymphoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE56857
|
MA0080.5
|
SPI1 |
RS4-11 (adult B acute lymphoblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE71616
|
MA0080.5
|
SPI1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE74999
|
MA0080.5
|